STOCK TITAN

AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Aurora Spine Corporation, a medical device manufacturer, will be participating in the NANS Annual Meeting to showcase its Sacroiliac Joint fusion products. The company will also present data from a recent clinical evaluation of its ZIP Interspinous Fixation device.
Positive
  • None.
Negative
  • None.

CARLSBAD, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the North American Neuromodulation Society (“NANS”) Annual Meeting from January 18-21 in Las Vegas, Nevada. The NANS Annual Meeting is a prominent medical conference that brings together healthcare professionals, researchers, and experts in the field of neuromodulation.

Aurora will be showcasing two Sacroiliac Joint (SI Joint) fusion products. Silo TFX and Silo offer physicians options to stabilize the SI Joint, helping patients with access to treatment for their SI joint dysfunction.

Aurora Spine will be presenting data from the recent publication of the first 6-month clinical evaluation from the REFINE Screwless™ ZIP™ Study of its ZIP Interspinous Fixation device in the Journal of Pain Research.

About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at www.aurora-spine.com or www.aurorapaincare.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company’s products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward-looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Chad Clouse
Chief Financial Officer
(760) 424-2004

www.aurora-spine.com                                


FAQ

What is the purpose of Aurora Spine's participation in the NANS Annual Meeting?

Aurora Spine will be showcasing its Sacroiliac Joint fusion products at the NANS Annual Meeting.

What products will Aurora Spine be showcasing at the NANS Annual Meeting?

Aurora Spine will be showcasing its Silo TFX and Silo products to stabilize the SI Joint.

What data will Aurora Spine be presenting at the NANS Annual Meeting?

Aurora Spine will be presenting data from a recent clinical evaluation of its ZIP Interspinous Fixation device.

What is the ticker symbol for Aurora Spine Corporation?

The ticker symbol for Aurora Spine Corporation is ASAPF.

AURORA SPINE CORP

OTC:ASAPF

ASAPF Rankings

ASAPF Latest News

ASAPF Stock Data

22.91M
57.32M
25.5%
0%
Medical Devices
Healthcare
Link
United States of America
Toronto